Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F88EV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,079
Award facts
- Contract value 100% obligated
- $11,079.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $11,079.43. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RINVOQ is a JAK inhibitor used for treating rheumatoid arthritis and other inflammatory conditions, demonstrating the Defense Logistics Agency's continued procurement of specialized pharmaceutical products for military and veteran healthcare systems.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's significant IDC position reflects its established capability to efficiently fulfill federal procurement requirements for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F88EV?
SPE2DR26F88EV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F88EV worth?
The government has obligated $11,079 on SPE2DR26F88EV.
Is contract SPE2DR26F88EV an order under another contract?
Yes. SPE2DR26F88EV is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88EV competed?
The extent of competition for SPE2DR26F88EV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award